To ask the Secretary of State for Health and Social Care, what steps he is taking to monitor progress on access to new NHS-approved drugs for blood cancer patients.
The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effectiv...
Blood Cancer: Drugs